Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections

• 收藏
• 分享

专利权人:

GILEAD SCIENCES INC.

发明人:

RAMANATHAN SRINIVASAN

申请号：

NZ62989613

公开号：

NZ629896A

申请日:

2013.02.01

申请国别(地区):

NZ

年份:

2016

代理人:

摘要：

The use of the hemifumarate form of { 9-[(R)-2-[[(S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]phenoxyphosphinyl]methoxy]propyl]adenine} (tenofovir alafenamide hemifumarate) in combination with cobicistat is disclosed. In addition, the combination of tenofovir alafenamide hemifumarate, cobicistat, emtricitabine, and elvitegravir, and the combination of tenofovir alafenamide hemifumarate, cobicistat, emtricitabine, and darunavir, are disclosed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/